Status:
COMPLETED
Transdiagnostic iCBT for Depression and Anxiety
Lead Sponsor:
Centre for Addiction and Mental Health
Conditions:
Major Depressive Disorder
Social Anxiety Disorder
Eligibility:
All Genders
18-29 years
Phase:
NA
Brief Summary
This 8-week, pilot randomized, controlled trial to evaluate the benefits of transdiagnostic Internet-based CBT (iCBT) in young adults with MDD, SAD, PD or GAD. The investigators hypothesize that patie...
Detailed Description
Unipolar depression and anxiety disorders (particularly social anxiety disorder \[SAD\], generalized anxiety disorder \[GAD\] and panic disorder \[PD\]) are among the most common forms of mental illne...
Eligibility Criteria
Inclusion
- Age range (18-29 years).
- Primary diagnosis of MDD, SAD, PD and/or GAD, per the DSM-IV-TR.
- A score ≥17 on the first 17 items of the Hamilton Depression Rating Scale (HAM-D)55
- A score ≥17 on the Hamilton Anxiety Rating Scale (HAM-A)56.
- Score ≥50 on the Leibowitiz Social Anxiety Scale (LSAS),57 ≥10 on the Panic Disorder Severity Scale (PDSS)58 and/or ≥60 the Penn State Worry Questionnaire (PSWQ).59
- Currently unmedicated or on stable and adequate doses of medication for at least 4 weeks.
- Co-morbidities are allowed and will be documented.
Exclusion
- 1\. Primary diagnosis of any psychotic disorder or any other anxiety disorder (OCD, PTSD).
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2018
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT02266693
Start Date
August 1 2014
End Date
August 1 2018
Last Update
February 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Addiction and Mental Health
Toronto, Ontario, Canada, M5T 1R8